Literature DB >> 28178114

Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.

Sidharath Dev Thakur1, Pamela Araya, Graciela Borthagaray, Patricia Galarza, Alina Llop Hernandez, Daisy Payares, Olga Marina Sanabria Cruz, Maria Elena Trigoso Carvallo, Aura Helena Corredor, Jo-Anne R Dillon.   

Abstract

Seven countries in Latin America and the Caribbean report on (2010 and 2011) the susceptibility of 2235 isolates of Neisseria gonorrhoeae to 6 antibiotics. Thirteen isolates had ceftriaxone minimum inhibitory concentrations (MICs) of 0.125 to ≥ 0.25 mg/L. The percentage of resistant isolates to the following antibiotics was: azithromycin, 1.0% to 1.7%; ciprofloxacin, 42.1% to 36.2%; penicillin, 31% to 35%; tetracycline, 21.8% to 22.6%.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28178114     DOI： 10.1097/OLQ.0000000000000587

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  7 in total

1.  Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in Guangdong, China: in a background of rapidly rising epidemic.

Authors:  Xiaolin Qin; Yunhu Zhao; Wei Chen; Xingzhong Wu; Sanmei Tang; Guozhou Li; Yu Yuqi; Wenling Cao; Xiaofeng Liu; Jinmei Huang; Jieyi Yang; Wentao Chen; Weiming Tang; Heping Zheng
Journal:  Int J Antimicrob Agents       Date:  2019-08-16       Impact factor: 5.283

Review 2.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.

Authors:  Magnus Unemo; Monica M Lahra; Michelle Cole; Patricia Galarza; Francis Ndowa; Irene Martin; Jo-Anne R Dillon; Pilar Ramon-Pardo; Gail Bolan; Teodora Wi
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

3.  Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020.

Authors:  Xiaomian Lin; Xiaolin Qin; Xingzhong Wu; Yiwen Liao; Yuqi Yu; Qinghui Xie; Sanmei Tang; Chixing Guo; Junming Pei; Zhizhou Wu; Changhui Cai; Feng Wang; Shanghua Wu; Heyong Chen; Xiaofeng Liu; Ming Li; Wenling Cao; Heping Zheng
Journal:  Antimicrob Agents Chemother       Date:  2022-03-29       Impact factor: 5.938

4.  Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.

Authors:  Teodora Wi; Monica M Lahra; Francis Ndowa; Manju Bala; Jo-Anne R Dillon; Pilar Ramon-Pardo; Sergey R Eremin; Gail Bolan; Magnus Unemo
Journal:  PLoS Med       Date:  2017-07-07       Impact factor: 11.069

5.  Increasing Resistance to Azithromycin in Neisseria gonorrhoeae in Eastern Chinese Cities: Resistance Mechanisms and Genetic Diversity among Isolates from Nanjing.

Authors:  Chuan Wan; Yang Li; Wen-Jing Le; Yu-Rong Liu; Sai Li; Bao-Xi Wang; Peter A Rice; Xiao-Hong Su
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

6.  Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.

Authors:  Suzette M Cameron-McDermott; Geoffrey J Barrow; Alicia M Webster; Carrington O De La Haye; Denise H E Wood; Violet M Lewis; Alison Nicholson; Glendee Y Reynolds-Campbell; Camille-Ann A Thoms-Rodriguez; Karen J Roye-Green; Nakeisha Otto-Stewart; Zahra N Miller; Jennifer A Tomlinson; Nicola Skyers; Magnus Unemo; Joshua J Anzinger
Journal:  J Antimicrob Chemother       Date:  2021-12-24       Impact factor: 5.790

7.  Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.

Authors:  Anthony D Cristillo; Claire C Bristow; Elizabeth Torrone; Jo-Anne Dillon; Robert D Kirkcaldy; Huan Dong; Yonatan H Grad; Robert A Nicholas; Peter A Rice; Kenneth Lawrence; David Oldach; William Maurice Shafer; Pei Zhou; Teodora E Wi; Sheldon R Morris; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2019-03       Impact factor: 2.830
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.